UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 84

Sortiert nach

Identification of Human Neutralization-Inducing Regions of the Human Immunodeficiency Virus Type 1 Envelope Glycoproteins

Proceedings of the National Academy of Sciences - PNAS, 1992-01, Vol.89 (2), p.461-465

1992

Volltextzugriff (PDF)

Cellular and humoral antigenic epitopes in HIV and SIV

Immunology, 1992-08, Vol.76 (4), p.515-534

1992

Volltextzugriff (PDF)

Presence of Maternal Antibodies to Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 Epitopes Correlates with the Uninfected Status of Children Born to Seropositive Mothers

Proceedings of the National Academy of Sciences - PNAS, 1989-10, Vol.86 (20), p.8055-8058

1989

Volltextzugriff (PDF)

Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers

The Journal of infectious diseases, 1990-02, Vol.161 (2), p.198

1990

Volltextzugriff (PDF)

Antibody‐dependent cellular cytotoxicity and neutralizing activity in sera of HIV‐1‐infected mothers and their children

Clinical and experimental immunology, 1993-07, Vol.93 (1), p.56-64

1993

Volltextzugriff (PDF)

Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides

Immunology, 1989-08, Vol.67 (4), p.453-459

1989

Volltextzugriff (PDF)

Human MoAbs produced from normal, HIV‐1‐negative donors and specific for glycoprotein gp 120 of the HIV‐1 envelope

Clinical and experimental immunology, 2008-06, Vol.89 (2), p.290-295

2008

Volltextzugriff (PDF)

Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp160

Journal of acquired immune deficiency syndromes (1988), 1994-03, Vol.7 (3), p.220-229

1994

Volltextzugriff (PDF)

IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages

Clinical and experimental immunology, 1988-09, Vol.73 (3), p.343-347

1988

Volltextzugriff (PDF)

Mutation in the TACI gene and autoimmune neutropenia: A case report

American journal of hematology, 2022-06, Vol.97 (6), p.E207-E210

2022

Volltextzugriff (PDF)

Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease

Bone marrow transplantation (Basingstoke), 2004-10, Vol.34 (7), p.589-593

2004

Volltextzugriff (PDF)

Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies

Immunology, 1991-08, Vol.73 (4), p.371-376

1991

Volltextzugriff (PDF)

Immunological and virological interactions in patients receiving passive immunotherapy with HIV-1 neutralizing monoclonal antibodies

Journal of acquired immune deficiency syndromes (1988), 1994-09, Vol.7 (9), p.940-951

1994

Volltextzugriff (PDF)

Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients

Clinical and experimental immunology, 1989-05, Vol.76 (2), p.216-221

1989

Volltextzugriff (PDF)

A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralization

Journal of Virology, 1990-02, Vol.64 (2), p.936-940

1990

Volltextzugriff (PDF)

Human monoclonal antibodies against a recombinant HIV envelope antigen produced by primary in vitro immunization: characterization and epitope mapping

Immunology, 1989-11, Vol.68 (3), p.325-331

1989

Volltextzugriff (PDF)

Human MoAbs produced from normal, HIV-1 negative donors and specific for glycoprotein gp120 of the HIV-1 envelope

Clinical and experimental immunology, 1992-08, Vol.89 (2), p.290-295

1992

Volltextzugriff (PDF)

Analysis of a subclass-restricted HIV-1 gp41 epitope by omission peptides

Immunology, 1989-05, Vol.67 (1), p.1-7

1989

Volltextzugriff (PDF)

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)

Blood, 2002-08, Vol.100 (3), p.768-773

2002

Volltextzugriff (PDF)

Monoclonal antibodies to conserved regions of the major core protein (gag24) of HIV-1 and HIV-2

AIDS research and human retroviruses, 1991, Vol.7 (1), p.97-101

1991

Volltextzugriff (PDF)

Specific synthetic peptides for detection of and discrimination between HIV-1 and HIV-2 infection

Journal of acquired immune deficiency syndromes (1988), 1991, Vol.4 (10), p.952-958

1991

Volltextzugriff (PDF)

Identification of B-cell antigenic sites on HIV-2 gp125

Journal of acquired immune deficiency syndromes (1988), 1992, Vol.5 (2), p.177-187

1992

Volltextzugriff (PDF)

HIV-1-specific antibodies in cerebrospinal fluid mediate cellular cytotoxicity and neutralization

AIDS research and human retroviruses, 1989-12, Vol.5 (6), p.629-638

1989

Volltextzugriff (PDF)

Analyses of functional antibody responses in HIV-1-infected individuals after vaccination with rgp160

Clinical and diagnostic virology, 1996-08, Vol.6 (2), p.115-126

1996

Volltextzugriff (PDF)

A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates

Journal of acquired immune deficiency syndromes and human retrovirology, 1996-07, Vol.12 (3), p.221

1996

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAids

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(61)
Humans
(58)
Life Sciences & Biomedicine
(54)
Medicin Och Hälsovetenskap
(52)
Biological And Medical Sciences
(34)
Female
(32)
Immunology
(32)
Aids/hiv
(27)
Infectious Diseases
(26)
Male
(23)
Virology
(22)
Adult
(20)
Microbiology
(20)
Hiv
(19)
Hiv-1 - Immunology
(19)
Medical Sciences
(19)
Fundamental And Applied Biological Sciences. Psychology
(18)
Human Immunodeficiency Virus
(15)
Amino Acid Sequence
(13)
Molecular Sequence Data
(13)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Identification of Human Neutralization-Inducing Regions of the Human Immunodeficiency Virus Type 1 Envelope Glycoproteins

Cellular and humoral antigenic epitopes in HIV and SIV

Presence of Maternal Antibodies to Human Immunodeficiency Virus 1 Envelope Glycoprotein gp120 Epitopes Correlates with the Uninfected Status of Children Born to Seropositive Mothers

Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers

Antibody‐dependent cellular cytotoxicity and neutralizing activity in sera of HIV‐1‐infected mothers and their children

Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides

Human MoAbs produced from normal, HIV‐1‐negative donors and specific for glycoprotein gp 120 of the HIV‐1 envelope

Improved cell-mediated immune responses in HIV-1-infected asymptomatic individuals after immunization with envelope glycoprotein gp160

IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages

Mutation in the TACI gene and autoimmune neutropenia: A case report

Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease

Identification of amino acids in the V3 region of gp120 critical for virus neutralization by human HIV-1-specific antibodies

Immunological and virological interactions in patients receiving passive immunotherapy with HIV-1 neutralizing monoclonal antibodies

Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients

A monoclonal antibody to human immunodeficiency virus type 1 which mediates cellular cytotoxicity and neutralization

Human monoclonal antibodies against a recombinant HIV envelope antigen produced by primary in vitro immunization: characterization and epitope mapping

Human MoAbs produced from normal, HIV-1 negative donors and specific for glycoprotein gp120 of the HIV-1 envelope

Analysis of a subclass-restricted HIV-1 gp41 epitope by omission peptides

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)

Monoclonal antibodies to conserved regions of the major core protein (gag24) of HIV-1 and HIV-2

Specific synthetic peptides for detection of and discrimination between HIV-1 and HIV-2 infection

Identification of B-cell antigenic sites on HIV-2 gp125

HIV-1-specific antibodies in cerebrospinal fluid mediate cellular cytotoxicity and neutralization

Analyses of functional antibody responses in HIV-1-infected individuals after vaccination with rgp160

A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates

Aktive Filter

Suchergebnisse filtern